FDA forthcoming on heparin investigation

The Food and Drug Administration's (FDA) announcement that the toxin in heparin is over-sulfated chondroitin sulfate demonstrated unusual efficiency by the agency

The Food and Drug Administration's (FDA) announcement that the toxin in heparin is over-sulfated chondroitin sulfate demonstrated unusual efficiency by the agency. Just hours after the word began to circulate about the contaminant, the FDA made the announcement, providing as much information about the investigation as possible. Federal officials stopped short of saying whether the contaminant was added to the drug intentionally, but with 19 deaths and hundreds of allergic reactions caused by the tainted blood-thinner, expect more swift communication from an agency that is usually not quite so forthcoming.

Also:

Hoping to get off the defensive about his connection to the controversial Rev. Jeremiah Wright, Jr., Barack Obama is to be endorsed today by Bill Richardson.

GoCrossCampus takes college rivalries online, and creates the latest college campus phenomenon.

Might Rupert Murdoch be interested in Newsday now?

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

Would you like to post a comment?

Please Sign in or register.